VRCA
Verrica Pharmaceuticals (VRCA)
$26
About Verrica Pharmaceuticals (VRCA)
Verrica Pharmaceuticals, Inc. is a dermatology therapeutics company, which engages in identifying, developing, and commercializing pharmaceutical products for the treatment of skin diseases. Its products include Pipeline VP-102, Pipeline VP-103, and Pipeline VP-315. The company was founded by Matthew Davidson on July 3, 2013 and is headquartered in West Chester, PA.
Details
Daily high
$6.57
Daily low
$6.26
Price at open
$6.57
52 Week High
$9.82
52 Week Low
$3.28
Market cap
107.5M
Dividend yield
0.00%
Volume
14,051
Avg. volume
43,810
P/E ratio
-6.05
Verrica Pharmaceuticals News
Details
Daily high
$6.57
Daily low
$6.26
Price at open
$6.57
52 Week High
$9.82
52 Week Low
$3.28
Market cap
107.5M
Dividend yield
0.00%
Volume
14,051
Avg. volume
43,810
P/E ratio
-6.05